Want to see IN:KIMS full AI Analyst Report?
KIMS Stock Chart & Stats
₹797.25
₹2.60(0.33%)
At close: 4:00 PM EDT
₹797.25
₹2.60(0.33%)
Day’s Range― - ―
52-Week Range₹575.55 - ₹858.15
Previous CloseN/A
Volume392.18K
Average Volume (3M)118.48K
Market Cap
₹279.79B
Enterprise Value₹293.76B
Total Cash (Recent Filing)₹1.74B
Total Debt (Recent Filing)₹31.87B
Price to Earnings (P/E)131.7
Beta0.79
Next Earnings
Nov 06, 2026EPS Estimate
2.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.39
Shares Outstanding420,006,470
10 Day Avg. Volume15,742
30 Day Avg. Volume118,479
Financial Highlights & Ratios
PEG Ratio-2.77
Price to Book (P/B)11.07
Price to Sales (P/S)6.37
P/FCF Ratio-22.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)10.36
Revenue Forecast (FY)₹51.96B
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthSustained multi-year revenue expansion indicates that KIMS is increasing patient demand and scaling its hospital platform. Continued growth after several years of expansion supports a durable opportunity to build clinical volumes, improve capacity utilization, and strengthen its position across served markets.
Diversified Hospital ServicesA broad hospital and clinical-services platform gives KIMS multiple ways to serve patients and capture revenue across the care pathway. The combination of complex care, procedures, diagnostics, and ancillary services can support recurring demand and reduce reliance on any single treatment category.
Positive Operating Cash ConversionOperating cash flow exceeding reported net income indicates that the core business is generating cash before its substantial expansion investment. This provides an internal funding base for operations and some reinvestment, even though overall free cash flow remains pressured by heavy capital spending.
Bears Say
Rising LeverageThe sharp increase in debt relative to equity raises financial risk and reduces flexibility if growth or profitability weakens. Higher leverage can also constrain future capital allocation, increase financing burdens, and make the company more dependent on successful execution of its expansion plans.
Deeply Negative Free Cash FlowPersistent negative free cash flow shows that investment requirements are substantially exceeding internally generated cash. While spending may support hospital expansion, the ongoing shortfall increases dependence on debt or other external funding and raises the financial risk of pursuing growth at this pace.
Margin And Return DeteriorationProfitability has weakened materially even as revenue continues to grow, suggesting that costs, case mix, or realizations are reducing the earnings contribution from each rupee of sales. Lower margins and ROE make it harder to generate attractive returns on the capital being invested.
Krishna Institute of Medical Sciences Limited News
KIMS FAQ
What was Krishna Institute of Medical Sciences Limited’s price range in the past 12 months?
Krishna Institute of Medical Sciences Limited lowest stock price was ₹575.55 and its highest was ₹858.15 in the past 12 months.
What is Krishna Institute of Medical Sciences Limited’s market cap?
Krishna Institute of Medical Sciences Limited’s market cap is ₹279.79B.
When is Krishna Institute of Medical Sciences Limited’s upcoming earnings report date?
Krishna Institute of Medical Sciences Limited’s upcoming earnings report date is Nov 06, 2026 which is in 11 days.
How were Krishna Institute of Medical Sciences Limited’s earnings last quarter?
Krishna Institute of Medical Sciences Limited released its earnings results on Aug 03, 2026. The company reported ₹1 earnings per share for the quarter, missing the consensus estimate of ₹1.483 by -₹0.483.
Is Krishna Institute of Medical Sciences Limited overvalued?
According to Wall Street analysts Krishna Institute of Medical Sciences Limited’s price is currently Overvalued.
Does Krishna Institute of Medical Sciences Limited pay dividends?
Krishna Institute of Medical Sciences Limited does not currently pay dividends.
What is Krishna Institute of Medical Sciences Limited’s EPS estimate?
Krishna Institute of Medical Sciences Limited’s EPS estimate is 2.01.
How many shares outstanding does Krishna Institute of Medical Sciences Limited have?
Krishna Institute of Medical Sciences Limited has 420,006,470 shares outstanding.
What happened to Krishna Institute of Medical Sciences Limited’s price movement after its last earnings report?
Krishna Institute of Medical Sciences Limited reported an EPS of ₹1 in its last earnings report, missing expectations of ₹1.483. Following the earnings report the stock price went up 1.964%.
Which hedge fund is a major shareholder of Krishna Institute of Medical Sciences Limited?
Currently, no hedge funds are holding shares in IN:KIMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Krishna Institute of Medical Sciences Limited
Krishna Institute of Medical Sciences Limited, known by its brand KIMS Hospitals across India, delivers a broad spectrum of medical and healthcare services. The institution boasts a comprehensive array of specialized fields, including cardiology, dentistry, neurology, oncology, orthopedics, nephrology, reproductive medicine, and robotic surgeries. Additionally, it offers expertise in gastroenterology, hepatology, heart and lung transplantation, general organ transplantation, maternal and pediatric care. Other key areas of focus include emergency and accident services, biochemistry, anesthesiology, bariatric surgery, andrology and infertility treatments, arthroscopy, Alzheimer's care, and dedicated bone and joint centers. Founded in 1973, the company is headquartered in Secunderabad, India.
Technical Analysis
Apollo Hospitals Enterprise Limited
―
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―